FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118352804> ?p ?o ?g. }

• W3118352804 endingPage "227" @default.
• W3118352804 startingPage "215" @default.
• W3118352804 abstract "Background/Aim: KT2 is a lysine/tryptophan-rich peptide modified from Crocodylus siamensis Leucrocin I. In this study, we examined the cell toxicity, cellular uptake, anti-migration and anti-invasion activities of KT2 in A375.S2 human melanoma cells. Materials and Methods: A375.S2 cells were treated with KT2 peptide and then we performed MTT assay, study of cellular uptake by a confocal microscope, wound healing assay, transwell migration/invasion assay, and evaluation of the expression of metastasis-associated proteins. Results: KT2 can be internalized through the plasma membrane and can slightly alter cell morphology, decrease the percentage of viable cells and inhibit cell migration and invasion of A375.S2 cells in a dose-dependent manner. This peptide suppressed MMP-2 activity, as measured by gelatine zymography assay. The protein level of MMP-2 was decreased by KT2. KT2 also down-regulated metastasis pathway-related molecules, including FAK, RhoA, ROCK1, GRB2, SOS-1, p-JNK, p-c-Jun, PI3K, p-AKT (Thr308), p-AKT (Ser473), p-p38, MMP-9, NF-kB, and uPA. Conclusion: These results indicate that KT2 inhibits the migration and invasion of human melanoma cells by decreasing MMP-2 and MMP-9 expression through inhibition of FAK, uPA, MAPK, PI3K/AKT NF-kB, and RhoA–ROCK signalling pathways. These findings suggest that KT2 deserves further investigation as an anti-metastatic agent for human melanoma." @default.
• W3118352804 created "2021-01-18" @default.
• W3118352804 creator A5001995156 @default.
• W3118352804 creator A5028423755 @default.
• W3118352804 creator A5043390109 @default.
• W3118352804 creator A5051812939 @default.
• W3118352804 creator A5072700965 @default.
• W3118352804 creator A5073626662 @default.
• W3118352804 creator A5075920642 @default.
• W3118352804 creator A5089201909 @default.
• W3118352804 creator A5090879205 @default.
• W3118352804 date "2021-01-01" @default.
• W3118352804 modified "2023-10-10" @default.
• W3118352804 title "Anti-metastatic Effects of Cationic KT2 Peptide (a Lysine/Tryptophan-rich Peptide) on Human Melanoma A375.S2 Cells" @default.
• W3118352804 cites W1485856781 @default.
• W3118352804 cites W1580931878 @default.
• W3118352804 cites W1975045288 @default.
• W3118352804 cites W2000241906 @default.
• W3118352804 cites W2002321849 @default.
• W3118352804 cites W2003960631 @default.
• W3118352804 cites W2013001916 @default.
• W3118352804 cites W2029137696 @default.
• W3118352804 cites W2044423100 @default.
• W3118352804 cites W2048864215 @default.
• W3118352804 cites W2061784494 @default.
• W3118352804 cites W2085274813 @default.
• W3118352804 cites W2086641174 @default.
• W3118352804 cites W2101322634 @default.
• W3118352804 cites W2109598625 @default.
• W3118352804 cites W2118863192 @default.
• W3118352804 cites W2124016062 @default.
• W3118352804 cites W2132675019 @default.
• W3118352804 cites W2173073542 @default.
• W3118352804 cites W2209093312 @default.
• W3118352804 cites W2235523093 @default.
• W3118352804 cites W2290750088 @default.
• W3118352804 cites W2299460155 @default.
• W3118352804 cites W2317835656 @default.
• W3118352804 cites W2408817953 @default.
• W3118352804 cites W2466934118 @default.
• W3118352804 cites W2483834612 @default.
• W3118352804 cites W2566027269 @default.
• W3118352804 cites W2598922467 @default.
• W3118352804 cites W2603655232 @default.
• W3118352804 cites W2614388893 @default.
• W3118352804 cites W2747897200 @default.
• W3118352804 cites W2761845985 @default.
• W3118352804 cites W2783047445 @default.
• W3118352804 cites W2789981169 @default.
• W3118352804 cites W2791722377 @default.
• W3118352804 cites W2793695854 @default.
• W3118352804 cites W2883972494 @default.
• W3118352804 cites W2888915719 @default.
• W3118352804 cites W2944523360 @default.
• W3118352804 cites W38030205 @default.
• W3118352804 cites W1509559846 @default.
• W3118352804 cites W1837150540 @default.
• W3118352804 doi "https://doi.org/10.21873/invivo.12250" @default.
• W3118352804 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7880745" @default.
• W3118352804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33402468" @default.
• W3118352804 hasPublicationYear "2021" @default.
• W3118352804 type Work @default.
• W3118352804 sameAs 3118352804 @default.
• W3118352804 citedByCount "6" @default.
• W3118352804 countsByYear W31183528042021 @default.
• W3118352804 countsByYear W31183528042022 @default.
• W3118352804 countsByYear W31183528042023 @default.
• W3118352804 crossrefType "journal-article" @default.
• W3118352804 hasAuthorship W3118352804A5001995156 @default.
• W3118352804 hasAuthorship W3118352804A5028423755 @default.
• W3118352804 hasAuthorship W3118352804A5043390109 @default.
• W3118352804 hasAuthorship W3118352804A5051812939 @default.
• W3118352804 hasAuthorship W3118352804A5072700965 @default.
• W3118352804 hasAuthorship W3118352804A5073626662 @default.
• W3118352804 hasAuthorship W3118352804A5075920642 @default.
• W3118352804 hasAuthorship W3118352804A5089201909 @default.
• W3118352804 hasAuthorship W3118352804A5090879205 @default.
• W3118352804 hasBestOaLocation W31183528041 @default.
• W3118352804 hasConcept C137738243 @default.
• W3118352804 hasConcept C1491633281 @default.
• W3118352804 hasConcept C153911025 @default.
• W3118352804 hasConcept C185592680 @default.
• W3118352804 hasConcept C2777093181 @default.
• W3118352804 hasConcept C502942594 @default.
• W3118352804 hasConcept C55493867 @default.
• W3118352804 hasConcept C62112901 @default.
• W3118352804 hasConcept C62478195 @default.
• W3118352804 hasConcept C75217442 @default.
• W3118352804 hasConcept C86554907 @default.
• W3118352804 hasConcept C86803240 @default.
• W3118352804 hasConcept C95444343 @default.
• W3118352804 hasConceptScore W3118352804C137738243 @default.
• W3118352804 hasConceptScore W3118352804C1491633281 @default.
• W3118352804 hasConceptScore W3118352804C153911025 @default.
• W3118352804 hasConceptScore W3118352804C185592680 @default.
• W3118352804 hasConceptScore W3118352804C2777093181 @default.
• W3118352804 hasConceptScore W3118352804C502942594 @default.
• W3118352804 hasConceptScore W3118352804C55493867 @default.

• next